Here, the authors profile different PC subsets in naïve and lupus-prone mice and report the emergence and expansion of a CD19– PC subset in diseased mice that could compromise the effectiveness of CD19-targeting therapies. The gene discussed is CD19; the disease is systemic lupus erythematosus.